SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving Possible Securities Fraud V...
September 20 2016 - 4:03PM
Business Wire
Levi & Korsinsky, LLP announces that it has commenced an
investigation of Spectrum Pharmaceuticals, Inc. (“Spectrum” or the
“Company”) (NASDAQ:SPPI) concerning possible violations of federal
securities laws by the Company.
On September 14, 2016, an advisory committee to the U.S. Food
and Drug Administration (“FDA”) unanimously voted
against approval of Spectrum’s bladder cancer treatment, Qapzola™.
Following this news, shares of Spectrum fell $0.45 per share from
its previous closing price to close at $5.04 per share on September
14, 2016.
Then on September 16, 2016, an article published by TheStreet
revealed that in a December 2012 meeting with the FDA, Spectrum was
advised not to file a New Drug Application for Qapzola. Despite
this advice, Spectrum told investors in a May 2015 conference call
that “we took this data, met with the FDA, and our understanding is
and our decision is that we can go ahead and file the NDA with this
drug.”
To obtain additional information about the investigation, go
to:
http://zlk.9nl.com/spectrumsppi
or contact Joseph E. Levi, Esq. either via email at
jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877)
363-5972.
Levi & Korsinsky is a national firm with offices in New
York, New Jersey, Connecticut and Washington D.C. The firm’s
attorneys have extensive expertise in prosecuting securities
litigation involving financial fraud, representing investors
throughout the nation in securities and shareholder lawsuits.
Attorney advertising. Prior results do not guarantee similar
outcomes.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160920006821/en/
Levi & Korsinsky, LLPJoseph E. Levi, Esq.Tel:
212-363-7500Toll Free: 877-363-5972Fax: 212-363-7171www.zlk.com
Spectrum Pharmaceuticals (NASDAQ:SPPI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Spectrum Pharmaceuticals (NASDAQ:SPPI)
Historical Stock Chart
From Apr 2023 to Apr 2024